Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Published bySabine Geiger Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease."— Presentation transcript:

1 Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD
Figure 3 | Energy metabolism regulation, cardiovascular and bone disease in CKD. Altered levels of several molecules such as bone morphogenetic protein (BMP), 1,25-dihydroxyvitamin D, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF-23), insulin, uraemic toxins and cardiac natriuretic peptides, as well as dysfunctional processes such as altered energy balance, adipocyte function, blood pressure and volume control are key risk factors for chronic kidney disease (CKD), bone disease and cardiovascular disease. Zoccali, C. et al. (2017) The systemic nature of CKD Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease."

Similar presentations

A.M. Thompson, T.G. Pickering  Kidney International 

A.M. Thompson, T.G. Pickering  Kidney International 
Endocrine System.

Endocrine System.
Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).

Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).
Volume 67, Pages S1-S7 (June 2005)

Volume 67, Pages S1-S7 (June 2005)
CKD–Mineral and Bone Disorder: Core Curriculum 2011

CKD–Mineral and Bone Disorder: Core Curriculum 2011
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),

Figure 4 Interplay between acute kidney injury (AKI),
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.

Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 6 Differences in glycaemic control with the study drug

Figure 6 Differences in glycaemic control with the study drug
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 1 Types of coronary artery calcification

Figure 1 Types of coronary artery calcification
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
Figure 1 Circadian changes in energy metabolism and immune responses in CKD Figure 1 | Circadian changes in energy metabolism and immune responses in CKD.

Figure 1 Circadian changes in energy metabolism and immune responses in CKD Figure 1 | Circadian changes in energy metabolism and immune responses in CKD.
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Figure 3 The fat–intestine–kidney axis

Figure 3 The fat–intestine–kidney axis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Is it Important to Prevent and Treat Protein-Energy Wasting in Chronic Kidney Disease and Chronic Dialysis Patients?  Bereket Tessema Lodebo, MD, MPH,

Is it Important to Prevent and Treat Protein-Energy Wasting in Chronic Kidney Disease and Chronic Dialysis Patients?  Bereket Tessema Lodebo, MD, MPH,

Similar presentations

Ads by Google